Direct effects of oncogenic proteins or inhibitor treatments on signaling pathways are difficult to assess in transgenic mice. In this issue, Riemer et al. (2017. J. Cell Biol. https://doi.org/10.1083/jcb.201610058) demonstrate that oncogene-inducible organoids offer the experimental versatility of two-dimensional cell lines, while closely representing the in vivo situation.
Carla S. Verissimo, Rene Overmeer, Bas Ponsioen, Jarno Drost, Sander Mertens, Ingrid Verlaan-Klink, Bastiaan van Gerwen, Marieke van der Ven, Marc van de Wetering, David A. Egan, René Bernards, Hans Clevers, Johannes L. Bos, Hugo J.G. Snippert
Elisa De Crignis, Tanvir Hossain, Shahla Romal, Fabrizia Carofiglio, Panagiotis Moulos, Mir M. Khalid, Shringar Rao, Ameneh Bazrafshan, Monique M.A. Verstegen, Farzin Pourfarzad, Christina Koutsothanassis, Helmuth Gehart, Tsung Wai Kan, Robert-Jan Palstra, Charles A. Boucher, Jan N.M. IJzermans, Meritxell Huch, Sylvia F. Boj, Robert Vries, Hans Clevers, Luc J. W. van der Laan, Pantelis Hatzis,
Richard J. Rebello, Eric Kusnadi, Donald P. Cameron, Helen Pearson, Analia Lesmana, Jennifer R. Devlin, Denis Drygin, Ashlee K. Clark, Laura H. Porter, John Pedersen, Shahneen Sandhu, Gail P. Risbridger, Richard B. Pearson, Ross D. Hannan, Luc Furic
Richard J. Rebello, Eric Kusnadi, Donald P. Cameron, Analia Lesmana, Denis Drygin, Ashlee K. Clark, Laura H. Porter, Shahneen Sandhu, Gail P. Risbridger, Richard B. Pearson, Ross D. Hannan, Luc Furic
Discussion(0)
No comments yet. Be the first to comment.